Search clinical trials for: Prostatic Neoplasms Castration-Resistant
Total 108465 results
-
IRCCS San RaffaeleRecruiting
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Not yet recruitingProstate Cancer | Prostate Cancer Metastatic
-
Chinese University of Hong KongRecruitingProstate Cancer | Cardiovascular RiskHong Kong
-
National Cancer Institute (NCI)RecruitingProstatic Hyperplasia | Stress Urinary Incontinence | Urinary Urge IncontinenceUnited States
-
Hinova Pharmaceuticals Inc.RecruitingMetastatic Castration-resistant Prostate CancerChina
-
Case Comprehensive Cancer CenterNational Institutes of Health (NIH)RecruitingProstate Cancer | Malignant Neoplasm of Prostate | Secondary Malignant Neoplasm of ProstateUnited States
-
Acibadem UniversityRecruiting
-
H. Lee Moffitt Cancer Center and Research InstituteRecruiting
-
Duke UniversityMemorial Sloan Kettering Cancer Center; University of Wisconsin, MadisonRecruitingProstate Cancer | Castration-resistant Prostate Cancer | Prostate Adenocarcinoma | Prostate Cancer MetastaticUnited States
-
Bivision Pharmaceuticals, Inc.Recruiting
-
Resurge Therapeutics Inc.RecruitingLower Urinary Tract Symptoms | BPH (Benign Prostatic Hyperplasia)New Zealand, Australia
-
Merck Sharp & Dohme LLCOrion Corporation, Orion PharmaRecruitingProstatic Neoplasms | Metastatic Castration-resistant Prostate Cancer (mCRPC)Australia, Germany, United States, Puerto Rico, Israel, Korea, Republic of, Taiwan, China, Costa Rica, Guatemala, Spain, France, Hong Kong, Portugal, Romania, Chile, Czechia, Hungary, Italy, Sweden, Turkey, United Kingdom, Estonia, Ir... and more
-
Merck Sharp & Dohme LLCOrion Corporation, Orion PharmaRecruitingProstatic Neoplasms | Metastatic Castration-Resistant Prostate CancerChina
-
Merck Sharp & Dohme LLCOrion Corporation, Orion PharmaRecruitingProstate Cancer MetastaticCanada, Germany, United States, Israel, Puerto Rico, Poland, Taiwan, Korea, Republic of, Australia, Chile, China, France, Norway, Czechia, Finland, Hong Kong, Netherlands, Spain, Sweden, Turkey, Denmark, Hungary, Italy, United Kingdom, ... and more
-
Centre Georges Francois LeclercNot yet recruitingPatients With Metastatic Castration-resistant Prostate Cancer
-
DendreonNot yet recruitingMetastatic Castration-Resistant Prostate Cancer (mCRPC)
-
Jianbin BiNot yet recruitingMetastatic Hormone-Sensitive Prostate Cancer
-
University of OklahomaNot yet recruitingAndrogen Deprivation Therapy | Locally Advanced Prostate CancerUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)Recruiting
-
University of Kansas Medical CenterNational Cancer Institute (NCI)Not yet recruitingRelugolix in Combination With Radiation Therapy for Treating Patients With High Risk Prostate CancerStage IV Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8United States
-
ABX advanced biochemical compounds GmbHNot yet recruitingProstate Cancer | Newly-Diagnosed Prostate Cancer
-
Direction Centrale du Service de Santé des ArméesNot yet recruitingProstate CancerFrance, Guadeloupe
-
AstraZenecaRecruitingMetastatic Castration-Sensitive Prostate CancerUnited States, Canada, Spain, United Kingdom, Italy, Australia, Korea, Republic of, Belgium, Germany, Japan, Peru, France, China, India, Taiwan, Thailand, Austria, Brazil, Turkey, Malaysia, Finland, Netherlands, Chile, Hungary, Poland, Sw...
-
Turku University HospitalUniversity of TurkuRecruitingProstate Cancer | Prostate HyperplasiaFinland
-
NHS LothianNot yet recruitingLow Risk Prostate Cancer | Intermediate Risk Prostate Cancer | Localized Prostate Cancer
-
Yale UniversityPfizerRecruiting
-
University of MiamiVarian Medical SystemsNot yet recruiting
-
Emory UniversityNational Cancer Institute (NCI)RecruitingBiochemically Recurrent Prostate Carcinoma | Prostate AdenocarcinomaUnited States
-
Dana-Farber Cancer InstituteProgenics Pharmaceuticals, Inc.Not yet recruitingProstate Cancer | Metastatic Castration-resistant Prostate Cancer | Metastatic Castration-resistant Prostate CarcinomaUnited States
-
Jiangsu HengRui Medicine Co., Ltd.Not yet recruitingHigh-volume, Metastatic, Hormone-sensitive Prostate Cancer (mHSPC)
-
Yale UniversityDendreonRecruitingMetastatic Castration-resistant Prostate CancerUnited States
-
National Cancer Institute (NCI)RecruitingRecurrent Prostate Cancer | Prostate Cancer | PET PositiveUnited States
-
Yonsei UniversityNot yet recruiting
-
Fred Hutchinson Cancer CenterBristol-Myers SquibbNot yet recruitingStage IV Prostate Cancer AJCC v8 | Prostate Carcinoma | Stage III Prostate Cancer AJCC v8 | Prostate Small Cell Neuroendocrine CarcinomaUnited States
-
Janssen Research & Development, LLCRecruitingAdvanced Prostate CancerFrance, United States
-
The Netherlands Cancer InstituteRecruiting
-
M.D. Anderson Cancer CenterRecruiting
-
M.D. Anderson Cancer CenterRecruitingProstate Cancer | Radical ProstatectomyUnited States
-
VA Office of Research and DevelopmentRecruitingProstate CancerUnited States
-
Sinotau Pharmaceutical GroupRecruitingProstate CancerChina
-
University of AlbertaRecruitingProstate Cancer | Metabolic Disease | IncontinenceCanada
-
Lantheus Medical ImagingRecruitingProstate CancerUnited States
-
Power Life Sciences Inc.Not yet recruitingRecurrent Prostate CancerUnited States
-
European Institute of OncologyAzienda Ospedaliera Universitaria Integrata Verona; Azienda Socio Sanitaria...Recruiting
-
Bristol-Myers SquibbRecruitingMetastatic Castration-resistant Prostate CancerUnited States
-
Jonsson Comprehensive Cancer CenterJanssen Scientific Affairs, LLCRecruitingProstate Adenocarcinoma | Stage II Prostate Cancer AJCC v8 | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8United States
-
University of Southern CaliforniaNational Cancer Institute (NCI)Recruiting
-
M.D. Anderson Cancer CenterBlue Earth TherapeuticsRecruiting
-
Vivek NarayanNational Comprehensive Cancer NetworkRecruitingProstate CancerUnited States